Skip to main content
editorial
. 2019 Mar 15;8(1):13–23. doi: 10.1007/s40120-019-0129-0

Table 1.

DMD ranking based on efficacy attribute ‘reduces disease activity overall’ by experts

Efficacy attribute Ranking
1 2 3 4 5
Reduces disease activity overall Alemtuzumab Cladribine tablets Ocrelizumab Natalizumab Fingolimod

DMD disease-modifying drug